Filter Results:
(479)
Show Results For
- All HBS Web (479)
- Faculty Publications (185)
Show Results For
- All HBS Web (479)
- Faculty Publications (185)
- Student-Profile
Olivia Zhao
pros and cons of a public system facing increased privatization. Research Olivia’s research hones in on the pharmaceutical industry and looking at the lifecycle of a drug. “It... View Details
- 15 Dec 2024
- News
After Ozempic
these drugs, known as GLP-1 agonists, amounts to so much more than media buzz. In just a few years, they have ignited a wave of change that has transformed Novo Nordisk into Europe’s most valuable public company. The seismic shift is on track to continue reshaping the... View Details
- Fast Answer
Investing in Life Sciences - SIP Resources
Market research: BCC Research - Reports on major economic, scientific, and technological developments in industrial, pharmaceutical, and high technology worldwide. Frost & Sullivan - Reports and market trends encompassing various... View Details
- 06 Feb 2007
- First Look
First Look: February 6, 2007
inventors, including knowledge spillovers and agglomeration and the concentration of spinoffs. This work investigates a possible antecedent of inventor mobility: regional variation in the enforcement of postemployment non-compete covenants. While previous View Details
Keywords: Martha Lagace
- 01 Sep 2011
- News
MBA 101: HBS Commencements Pass the Century Mark
pharmaceutical executive at the time of her diagnosis with multiple myeloma, an incurable, rare, and little-researched blood cancer, Giusti went on to found the Multiple Myeloma Research Foundation and the... View Details
- 03 Dec 2001
- Research & Ideas
Healthcare Conference Looks At Ailing Industry
observations. Although healthcare as a whole still suffers from the elephant problem, it's suffering less all the time—at least where science is concerned—thanks to remarkable and ever-faster scientific advances. Chief among the advances is genomic View Details
- Profile
Paul Wang
work with the MIT’s Abdul Latif Jameel Poverty Action Lab (J-PAL). “They’re a group of economists who use randomized evaluation methodologies, similar to those used in pharmaceutical trials, to assess the impact of development projects,”... View Details
- 01 Mar 2007
- News
In Brief
Q&A with Daniel Vasella. Initially regarded by critics as too inexperienced to lead a major pharmaceutical company, Daniel Vasella (PMD 57, 1989) has set a new standard for innovation as CEO of Novartis. The Winning Season. Last year, St.... View Details
- 13 Feb 2006
- Research & Ideas
The Hidden Market for Babies
process of thinking about possibly adopting a third child (we already had two through old-fashioned means). And as I was doing personal research into adoption, it struck me one day that adoption was really just the flip side of... View Details
- 06 Mar 2018
- News
A Voice for Diversity and Impact at Scale
its Pharmaceutical and Medical Products Practice in Europe, the Middle East, and Africa. And as a member of the global board of directors, she has spearheaded flagship research linking diversity to... View Details
- 28 Mar 2023
- Blog Post
Novo Nordisk
learned details of how Novo Nordisk manufactures within its 1,200,000 square meter facility high-quality active pharmaceutical ingredients (APIs) that tackle not only diabetes but also hemophilia, growth disorders, and obesity. At their... View Details
- Fast Answer
Transforming Health Care Delivery
Neue",Helvetica,Arial,sans-serif; font-size: 14px; line-height: 20px; background-color: rgb(255, 255, 255);" width="698"> Research task Good for finding... Suggested... View Details
- 01 Sep 2006
- News
HBS Student Battles ALS
returned home. While there, he served as the head of Israel’s ALS nonprofit organization, IsrALS, instituting a campaign that galvanized funding, awareness, and research efforts in that nation. Kremer returned to HBS last January. Since... View Details
- Profile
Arjun Goyal
Coming from a family of doctors, Arjun Goyal anticipated a life in clinical medicine in his home country of Australia. But when his education directed him to a year of research at the University of Oxford in the United Kingdom, where he... View Details
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
the business world has an important leadership role to play in terms of closing the gap in health and other vital social issues," he says. When Ray Gilmartin joined Merck in June 1994 as president and CEO (he became chairman several months later), it was the first time... View Details
- 01 Jan 2004
- News
Donald P. Nielsen, MBA 1963
the CEO of the world's largest independent biomedical research and testing company. He set off on a two-year "odyssey" around the United States to try to figure out what was wrong with this country's public education system. Then he ran... View Details
- 15 Sep 2009
- First Look
First Look: September 15
http://www.nber.org/papers/w11503 Synthesis by Microbes or Chemists? Pharmaceutical Research and Manufacturing in the Antibiotic Era Author:Arthur A. Daemmrich Publication:History and Technology 23, no. 3... View Details
Keywords: Martha Lagace
- 11 May 2020
- Op-Ed
Immigration Policies Threaten American Competitiveness
It is no secret that immigration has reshaped American innovation. Immigrants are the backbone of America’s most innovative industries, provide a quarter of our patent applications, and are numerous among our science and engineering superstars. Taken from World... View Details
Keywords: by William R. Kerr
- 24 Jul 2014
- Op-Ed
Reform Tax Law to Keep US Firms at Home
I am a Professor of Finance at Harvard Business School, a Professor of Law at Harvard Law School, and a Research Associate of the National Bureau of Economic Research. Recent merger transactions highlight long-simmering problems in the US... View Details
- 01 Jun 2000
- News
The Right Connections
From genome research to e-commerce, new ventures are popping up everywhere, competing for the cash needed to turn them into successful enterprises. When trying to secure backing for a high-risk start-up, whom you know can be just as... View Details
Keywords: Judith A. Ross